Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project
Identifieur interne : 000940 ( France/Analysis ); précédent : 000939; suivant : 000941Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project
Auteurs : E. Flipon [France] ; M. Brazier [France] ; G. Clavel [France] ; P. Boumier [France] ; A. Gayet [France] ; X. Le Loët [France] ; P. Fardellone [France]Source :
- Fundamental & Clinical Pharmacology [ 0767-3981 ] ; 2009-02.
English descriptors
Abstract
This study was conducted to identify early predictors of the total cost of inflammatory arthritis (IA). One hundred and eighty patients affected by undifferentiated arthritis (UA) or rheumatoid arthritis (RA) were included in the French Very Early rheumatoid Arthritis (VErA) cohort between 1998 and 2001. Health economic data for 2003 were collected using a patient self‐questionnaire. Results were analysed in terms of direct, indirect and total costs in 2003 euros (2003€) for the population as a whole and in diagnostic subgroups. A payor perspective (the French National Health Insurance, in this case) was adopted. Multiple linear regression models were used to identify predictors of total cost from among the criteria assessed on recruitment. Results of the study showed that for the study population as a whole, the mean total cost was €4700 per patient. The costs attributable to the RA and UA sub‐groups were €5928 and €2424 per patient, respectively. In a univariate analysis, certain parameters were significantly correlated with a higher cost of illness. In the multivariate analysis, some of these parameters were further identified as being predictive of higher cost. Two strong significant, early predictors of total cost were identified: higher pain (P = 0.002) and the presence of rheumatoid factor (P = 0.004). In the RA sub‐group, lower grip strength of the dominant hand (P = 0.039) was another predictor of the illness’s subsequent economic impact. In conclusion, our data show that simple clinical and laboratory parameters can be used early in the course of IA to predict the condition’s impact on healthcare budgets.
Url:
DOI: 10.1111/j.1472-8206.2008.00645.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001593
- to stream Istex, to step Curation: 001593
- to stream Istex, to step Checkpoint: 000289
- to stream Main, to step Merge: 000C18
- to stream Main, to step Curation: 000C11
- to stream Main, to step Exploration: 000C11
- to stream France, to step Extraction: 000940
Links to Exploration step
ISTEX:B30FE9AE46D88D58409A2A2DC201DF293583F73FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project</title><author><name sortKey="Flipon, E" sort="Flipon, E" uniqKey="Flipon E" first="E." last="Flipon">E. Flipon</name></author><author><name sortKey="Brazier, M" sort="Brazier, M" uniqKey="Brazier M" first="M." last="Brazier">M. Brazier</name></author><author><name sortKey="Clavel, G" sort="Clavel, G" uniqKey="Clavel G" first="G." last="Clavel">G. Clavel</name></author><author><name sortKey="Boumier, P" sort="Boumier, P" uniqKey="Boumier P" first="P." last="Boumier">P. Boumier</name></author><author><name sortKey="Gayet, A" sort="Gayet, A" uniqKey="Gayet A" first="A." last="Gayet">A. Gayet</name></author><author><name sortKey="Le Loet, X" sort="Le Loet, X" uniqKey="Le Loet X" first="X." last="Le Loët">X. Le Loët</name></author><author><name sortKey="Fardellone, P" sort="Fardellone, P" uniqKey="Fardellone P" first="P." last="Fardellone">P. Fardellone</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B30FE9AE46D88D58409A2A2DC201DF293583F73F</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1111/j.1472-8206.2008.00645.x</idno><idno type="url">https://api.istex.fr/document/B30FE9AE46D88D58409A2A2DC201DF293583F73F/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001593</idno><idno type="wicri:Area/Istex/Curation">001593</idno><idno type="wicri:Area/Istex/Checkpoint">000289</idno><idno type="wicri:doubleKey">0767-3981:2009:Flipon E:is:it:possible</idno><idno type="wicri:Area/Main/Merge">000C18</idno><idno type="wicri:Area/Main/Curation">000C11</idno><idno type="wicri:Area/Main/Exploration">000C11</idno><idno type="wicri:Area/France/Extraction">000940</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project</title><author><name sortKey="Flipon, E" sort="Flipon, E" uniqKey="Flipon E" first="E." last="Flipon">E. Flipon</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Departments of Rheumatology and Biochemistry, Amiens University Hospital, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Laboratory, Research Unit on Bone Resorption Mechanisms, Faculties of Pharmacy & Medicine and INSERM ERI 12, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Brazier, M" sort="Brazier, M" uniqKey="Brazier M" first="M." last="Brazier">M. Brazier</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Departments of Rheumatology and Biochemistry, Amiens University Hospital, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Laboratory, Research Unit on Bone Resorption Mechanisms, Faculties of Pharmacy & Medicine and INSERM ERI 12, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Clavel, G" sort="Clavel, G" uniqKey="Clavel G" first="G." last="Clavel">G. Clavel</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Departments of Rheumatology and Biochemistry, Amiens University Hospital, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Boumier, P" sort="Boumier, P" uniqKey="Boumier P" first="P." last="Boumier">P. Boumier</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Departments of Rheumatology and Biochemistry, Amiens University Hospital, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Gayet, A" sort="Gayet, A" uniqKey="Gayet A" first="A." last="Gayet">A. Gayet</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Department of Rheumatology, Rouen University Hospital and INSERM U519, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Le Loet, X" sort="Le Loet, X" uniqKey="Le Loet X" first="X." last="Le Loët">X. Le Loët</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Department of Rheumatology, Rouen University Hospital and INSERM U519, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Fardellone, P" sort="Fardellone, P" uniqKey="Fardellone P" first="P." last="Fardellone">P. Fardellone</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Departments of Rheumatology and Biochemistry, Amiens University Hospital, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Laboratory, Research Unit on Bone Resorption Mechanisms, Faculties of Pharmacy & Medicine and INSERM ERI 12, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Fundamental & Clinical Pharmacology</title><idno type="ISSN">0767-3981</idno><idno type="eISSN">1472-8206</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2009-02">2009-02</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="105">105</biblScope><biblScope unit="page" to="113">113</biblScope></imprint><idno type="ISSN">0767-3981</idno></series><idno type="istex">B30FE9AE46D88D58409A2A2DC201DF293583F73F</idno><idno type="DOI">10.1111/j.1472-8206.2008.00645.x</idno><idno type="ArticleID">FCP645</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0767-3981</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>clinical and biological predictors</term><term>costs</term><term>inflammatory arthritis</term><term>rheumatoid arthritis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study was conducted to identify early predictors of the total cost of inflammatory arthritis (IA). One hundred and eighty patients affected by undifferentiated arthritis (UA) or rheumatoid arthritis (RA) were included in the French Very Early rheumatoid Arthritis (VErA) cohort between 1998 and 2001. Health economic data for 2003 were collected using a patient self‐questionnaire. Results were analysed in terms of direct, indirect and total costs in 2003 euros (2003€) for the population as a whole and in diagnostic subgroups. A payor perspective (the French National Health Insurance, in this case) was adopted. Multiple linear regression models were used to identify predictors of total cost from among the criteria assessed on recruitment. Results of the study showed that for the study population as a whole, the mean total cost was €4700 per patient. The costs attributable to the RA and UA sub‐groups were €5928 and €2424 per patient, respectively. In a univariate analysis, certain parameters were significantly correlated with a higher cost of illness. In the multivariate analysis, some of these parameters were further identified as being predictive of higher cost. Two strong significant, early predictors of total cost were identified: higher pain (P = 0.002) and the presence of rheumatoid factor (P = 0.004). In the RA sub‐group, lower grip strength of the dominant hand (P = 0.039) was another predictor of the illness’s subsequent economic impact. In conclusion, our data show that simple clinical and laboratory parameters can be used early in the course of IA to predict the condition’s impact on healthcare budgets.</div></front></TEI><affiliations><list><country><li>France</li></country><settlement><li>Amiens</li><li>Rouen</li></settlement></list><tree><country name="France"><noRegion><name sortKey="Flipon, E" sort="Flipon, E" uniqKey="Flipon E" first="E." last="Flipon">E. Flipon</name></noRegion><name sortKey="Boumier, P" sort="Boumier, P" uniqKey="Boumier P" first="P." last="Boumier">P. Boumier</name><name sortKey="Brazier, M" sort="Brazier, M" uniqKey="Brazier M" first="M." last="Brazier">M. Brazier</name><name sortKey="Brazier, M" sort="Brazier, M" uniqKey="Brazier M" first="M." last="Brazier">M. Brazier</name><name sortKey="Clavel, G" sort="Clavel, G" uniqKey="Clavel G" first="G." last="Clavel">G. Clavel</name><name sortKey="Fardellone, P" sort="Fardellone, P" uniqKey="Fardellone P" first="P." last="Fardellone">P. Fardellone</name><name sortKey="Fardellone, P" sort="Fardellone, P" uniqKey="Fardellone P" first="P." last="Fardellone">P. Fardellone</name><name sortKey="Flipon, E" sort="Flipon, E" uniqKey="Flipon E" first="E." last="Flipon">E. Flipon</name><name sortKey="Gayet, A" sort="Gayet, A" uniqKey="Gayet A" first="A." last="Gayet">A. Gayet</name><name sortKey="Le Loet, X" sort="Le Loet, X" uniqKey="Le Loet X" first="X." last="Le Loët">X. Le Loët</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000940 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000940 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:B30FE9AE46D88D58409A2A2DC201DF293583F73F
|texte= Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project
}}
| This area was generated with Dilib version V0.6.25. |  |